Cargando…
Observational study on quality of life, safety, and effectiveness of first‐line cetuximab plus chemotherapy in KRAS wild‐type metastatic colorectal cancer patients: the ObservEr Study
Cetuximab improves efficacy when added to chemotherapy for metastatic colorectal cancer (mCRC). Effective management of skin reactions from cetuximab improves quality of life (QoL), and treatment compliance in clinical trials. No data are available from real‐world settings. The ObservEr observationa...
Autores principales: | Pinto, Carmine, Di Fabio, Francesca, Rosati, Gerardo, Lolli, Ivan R., Ruggeri, Enzo M., Ciuffreda, Libero, Ferrari, Daris, Lo Re, Giovanni, Rosti, Giovanni, Tralongo, Paolo, Ferrara, Raimondo, Alabiso, Oscar, Chiara, Silvana, Ianniello, Giovanni P., Frassoldati, Antonio, Bilancia, Domenico, Campanella, Giovanna A., Signorelli, Carlo, Racca, Patrizia, Benincasa, Elena, Stroppolo, Maria Elena, Di Costanzo, Francesco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5119983/ https://www.ncbi.nlm.nih.gov/pubmed/27748041 http://dx.doi.org/10.1002/cam4.888 |
Ejemplares similares
-
Effectiveness and Costs Associated to Adding Cetuximab or Bevacizumab to Chemotherapy as Initial Treatment in Metastatic Colorectal Cancer: Results from the Observational FABIO Project
por: Franchi, Matteo, et al.
Publicado: (2020) -
The Role of Nutritional Support in Cured/Chronic Patients
por: Rosti, Giovanni, et al.
Publicado: (2020) -
Body mass index (BMI) influence on Cetuximab-induced antibody-dependent cellular cytotoxicity in advanced colon cancer
por: Tralongo, Antonino Carmelo, et al.
Publicado: (2022) -
Testicular tumors in the “elderly” population
por: Secondino, Simona, et al.
Publicado: (2022) -
Role of narrative-based medicine in proper patient assessment
por: Rosti, Giovanni
Publicado: (2017)